Vericel VCEL
NASDAQ VCEL
$40.19 -0.28 (-0.69%)
As of: Sep 4, 2026 · 3:59 PM EDT

Vericel (VCEL) Current Assets (2010 - 2026)

Vericel (VCEL) posted Current Assets of $264.7 million for Q2 2026, up 8.47% sequentially from $244.1 million in Q1 2026, and up 29.4% YoY from $204.6 million in Q2 2025.

Analysis

Vericel (VCEL) Current Assets (2010 - 2026) Analysis & Trends

Vericel has reported Current Assets for 17 years, with the latest figure at $264.7 million in Q2 2026.

  • Quarterly Current Assets rose 29.4% year-over-year to $264.7 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $264.7 million (up 29.4% YoY) and the FY2025 annual result came in at $247.4 million, up 16.29% from the prior year.
  • Current Assets improved to $264.7 million in Q2 2026 per VCEL's latest filing, from $244.1 million in the prior quarter.
  • Over five years, Current Assets peaked at $264.7 million in Q2 2026 and troughed at $151.9 million in Q1 2022.
  • A 5-year average of $199.1 million and a median of $194.0 million in 2024 frame the typical range for Current Assets.
  • The sharpest annual moves came in 2024 and 2026: Current Assets grew 2.31% in 2024, then gained 29.4% in 2026.
  • Over 5 years, Current Assets stood at $186.9 million in 2022, then gained by 10.04% to $205.6 million in 2023, then rose by 3.48% to $212.8 million in 2024, then grew by 16.29% to $247.4 million in 2025, then grew by 6.99% to $264.7 million in 2026.
  • According to Business Quant data, Current Assets over the past three periods registered $264.7 million, $244.1 million, and $247.4 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Assets (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 12.54 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 18.45 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 8.07 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 5.82 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 4.03 Bn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 7.22 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 4.62 Bn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 1.76 Bn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 1.63 Bn
10 Vericel 2.05 Bn 1.89 Bn 56.40 Mn 264.73 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 264.73 Mn
Mar 31, 2026 244.06 Mn
Dec 31, 2025 247.44 Mn
Sep 30, 2025 221.97 Mn
Jun 30, 2025 204.58 Mn
Mar 31, 2025 197.64 Mn
Dec 31, 2024 212.78 Mn
Sep 30, 2024 190.52 Mn
Jun 30, 2024 197.39 Mn
Mar 31, 2024 189.72 Mn
Dec 31, 2023 205.63 Mn
Sep 30, 2023 186.21 Mn
Jun 30, 2023 182.87 Mn
Mar 31, 2023 177.55 Mn
Dec 31, 2022 186.87 Mn
Sep 30, 2022 166.38 Mn
Jun 30, 2022 155.09 Mn
Mar 31, 2022 151.88 Mn
Dec 31, 2021 158.46 Mn
Sep 30, 2021 144.95 Mn